Axi-cel in PCNSL and SCNSL
This study investigated the safety and efficacy of axi-cel in 9 patients with PCNSL and SCNSL. The authors reported no increased risk of high-grade ICANS, cerebral oedema, or other neurologic events; Complete response rate was 86%.